Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 4, 2014
[ Fri, Apr 04th 2014
] - WOPRAI
[ Fri, Apr 04th 2014
] - WOPRAI
Thu, April 3, 2014
[ Thu, Apr 03rd 2014
] - WOPRAI
[ Thu, Apr 03rd 2014
] - WOPRAI
[ Thu, Apr 03rd 2014
] - WOPRAI
[ Thu, Apr 03rd 2014
] - WOPRAI
[ Thu, Apr 03rd 2014
] - WOPRAI
Wed, April 2, 2014
[ Wed, Apr 02nd 2014
] - WOPRAI
[ Wed, Apr 02nd 2014
] - WOPRAI
[ Wed, Apr 02nd 2014
] - WOPRAI
[ Wed, Apr 02nd 2014
] - WOPRAI
[ Wed, Apr 02nd 2014
] - WOPRAI
Tue, April 1, 2014
[ Tue, Apr 01st 2014
] - WOPRAI
[ Tue, Apr 01st 2014
] - WOPRAI
[ Tue, Apr 01st 2014
] - WOPRAI
[ Tue, Apr 01st 2014
] - WOPRAI
[ Tue, Apr 01st 2014
] - WOPRAI
Mon, March 31, 2014
[ Mon, Mar 31st 2014
] - WOPRAI
[ Mon, Mar 31st 2014
] - WOPRAI
[ Mon, Mar 31st 2014
] - WOPRAI
[ Mon, Mar 31st 2014
] - WOPRAI
Fri, March 28, 2014
[ Fri, Mar 28th 2014
] - WOPRAI
[ Fri, Mar 28th 2014
] - WOPRAI
Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $60 on, Mar 28th, 2014
Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $56 to $60 on, Mar 28th, 2014.
Liav has made no other calls on TEVA in the last 4 months.
There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Schott of "JP Morgan" Upgraded from Sell to Hold and Held Target at $49 on, Friday, March 14th, 2014
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014
- Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014
This is the rating of the analyst that currently disagrees with Liav
- Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
